Nanoformulations in the Treatment of Lung Cancer: Current Status and Clinical Potential DOI
Mahmoud A. Younis,

Mohammad A. Alsogaihi,

Ahmed A. H. Abdellatif

и другие.

Drug Development and Industrial Pharmacy, Год журнала: 2024, Номер unknown, С. 1 - 33

Опубликована: Дек. 4, 2024

Recent developments in nanotechnology have regained the hope enabling eradication of lung cancer, while overcoming drawbacks classic therapeutics. Nevertheless, there are still formidable obstacles that hinder translation such platforms from bench into clinic. Herein, we shed light on clinical potential these formulations and discuss their future directions.

Язык: Английский

Harnessing the composition of lipid nanoparticles to selectively deliver mRNA to splenic immune cells for anticancer vaccination DOI
Mahmoud A. Younis, Yusuke Sato, Yaser Hosny Ali Elewa

и другие.

Drug Delivery and Translational Research, Год журнала: 2025, Номер unknown

Опубликована: Март 7, 2025

Язык: Английский

Процитировано

0
Nanoformulations in the Treatment of Lung Cancer: Current Status and Clinical Potential DOI
Mahmoud A. Younis,

Mohammad A. Alsogaihi,

Ahmed A. H. Abdellatif

и другие.

Drug Development and Industrial Pharmacy, Год журнала: 2024, Номер unknown, С. 1 - 33

Опубликована: Дек. 4, 2024

Recent developments in nanotechnology have regained the hope enabling eradication of lung cancer, while overcoming drawbacks classic therapeutics. Nevertheless, there are still formidable obstacles that hinder translation such platforms from bench into clinic. Herein, we shed light on clinical potential these formulations and discuss their future directions.

Язык: Английский

Процитировано

2